mohammed ibn-mas'ud danjuma
Weill Cornell Medicine- Qatar
Ar-Rayyan, Qatar
Review Editor
Pharmacoepidemiology
Weill Cornell Medicine- Qatar
Ar-Rayyan, Qatar
Review Editor
Pharmacoepidemiology
School of Population Health, Faculty of Medicine, University of New South Wales
Sydney, Australia
Review Editor
Pharmacoepidemiology
Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
Barcelona, Spain
Review Editor
Pharmacoepidemiology
University of Massachusetts Medical School
Worcester, United States
Review Editor
Pharmacoepidemiology
Roche (United Kingdom)
Welwyn Garden City, United Kingdom
Review Editor
Pharmacoepidemiology
Federal University of Ceara
Fortaleza, Brazil
Review Editor
Pharmacoepidemiology
University of Brasilia
Brasilia, Brazil
Review Editor
Pharmacoepidemiology
IRCCS MultiMedica Hospital Sesto San Giovanni
Sesto San Giovanni, Italy
Review Editor
Pharmacoepidemiology
University of Bologna
Bologna, Italy
Review Editor
Pharmacoepidemiology
Long Island University-Brooklyn
Brooklyn, United States
Review Editor
Pharmacoepidemiology
School of Medicine, Wake Forest University
Winston-Salem, United States
Review Editor
Pharmacoepidemiology
Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
Barcelona, Spain
Review Editor
Pharmacoepidemiology
Bristol Myers Squibb (United States)
New York, United States
Review Editor
Pharmacoepidemiology
Novartis (United States)
East Hanover, United States
Review Editor
Pharmacoepidemiology
Faculty of Medical Sciences, National University of Cordoba
Córdoba, Argentina
Review Editor
Pharmacoepidemiology
University of Science Malaysia (USM)
Penang, Malaysia
Review Editor
Pharmacoepidemiology